BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24487911)

  • 1. (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.
    Esteves F; Lee CH; de Sousa B; Badura R; Seringa M; Fernandes C; Gaspar JF; Antunes F; Matos O
    Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1173-80. PubMed ID: 24487911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers.
    Esteves F; Calé SS; Badura R; de Boer MG; Maltez F; Calderón EJ; van der Reijden TJ; Márquez-Martín E; Antunes F; Matos O
    Clin Microbiol Infect; 2015 Apr; 21(4):379.e1-10. PubMed ID: 25630458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.
    Damiani C; Le Gal S; Da Costa C; Virmaux M; Nevez G; Totet A
    J Clin Microbiol; 2013 Oct; 51(10):3380-8. PubMed ID: 23903553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of the 1,3-beta-D-glucan test and lactate dehydrogenase for pneumocystis pneumonia in non-HIV patients.
    Sun R; Lv D; Xiao M; Zhang L; Xu J; Yu X; Zhu H; Yang J
    Sci Rep; 2021 Apr; 11(1):9226. PubMed ID: 33927297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.
    Salerno D; Mushatt D; Myers L; Zhuang Y; de la Rua N; Calderon EJ; Welsh DA
    Respir Med; 2014 Nov; 108(11):1688-95. PubMed ID: 25448310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.
    Hammarström H; Grankvist A; Broman I; Kondori N; Wennerås C; Gisslen M; Friman V
    BMC Infect Dis; 2019 Jul; 19(1):658. PubMed ID: 31337356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum indicators for the diagnosis of pneumocystis pneumonia.
    Tasaka S; Hasegawa N; Kobayashi S; Yamada W; Nishimura T; Takeuchi T; Ishizaka A
    Chest; 2007 Apr; 131(4):1173-80. PubMed ID: 17426225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.
    Sax PE; Komarow L; Finkelman MA; Grant PM; Andersen J; Scully E; Powderly WG; Zolopa AR;
    Clin Infect Dis; 2011 Jul; 53(2):197-202. PubMed ID: 21690628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy.
    Desmet S; Van Wijngaerden E; Maertens J; Verhaegen J; Verbeken E; De Munter P; Meersseman W; Van Meensel B; Van Eldere J; Lagrou K
    J Clin Microbiol; 2009 Dec; 47(12):3871-4. PubMed ID: 19846641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum (1 → 3)-β-D-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value.
    Held J; Koch MS; Reischl U; Danner T; Serr A
    Clin Microbiol Infect; 2011 Apr; 17(4):595-602. PubMed ID: 20673271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study.
    Engsbro AL; Najat S; Jørgensen KM; Kurtzhals JAL; Arendrup MC
    Med Mycol; 2019 Aug; 57(6):710-717. PubMed ID: 30535059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of β-D-glucan in diagnosis of suspected
    Juniper T; Eades CP; Gil E; Fodder H; Quinn K; Morris-Jones S; Gorton RL; Wey EQ; Post FA; Miller RF
    Int J STD AIDS; 2021 Oct; 32(11):1074-1077. PubMed ID: 34106017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.
    Tasaka S; Kobayashi S; Yagi K; Asami T; Namkoong H; Yamasawa W; Ishii M; Hasegawa N; Betsuyaku T
    J Infect Chemother; 2014 Nov; 20(11):678-81. PubMed ID: 25066434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.
    Nakamura H; Tateyama M; Tasato D; Haranaga S; Yara S; Higa F; Ohtsuki Y; Fujita J
    Intern Med; 2009; 48(4):195-202. PubMed ID: 19218768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of 1,3 Beta-D-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia.
    Lahmer T; da Costa CP; Held J; Rasch S; Ehmer U; Schmid RM; Huber W
    Mycopathologia; 2017 Aug; 182(7-8):701-708. PubMed ID: 28378239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-D-glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study.
    de Boer MG; Gelinck LB; van Zelst BD; van de Sande WW; Willems LN; van Dissel JT; de Jonge R; Kroon FP
    J Infect; 2011 Jan; 62(1):93-100. PubMed ID: 20970450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.
    Rogina P; Skvarc M
    Radiol Oncol; 2020 May; 54(2):221-226. PubMed ID: 32463392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.
    Son HJ; Sung H; Park SY; Kim T; Lee HJ; Kim SM; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    PLoS One; 2017; 12(11):e0188860. PubMed ID: 29190812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
    Del Bono V; Mularoni A; Furfaro E; Delfino E; Rosasco L; Miletich F; Viscoli C
    Clin Vaccine Immunol; 2009 Oct; 16(10):1524-6. PubMed ID: 19692624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Diagnosis of Pneumocystis Pneumonia.
    Song Y; Ren Y; Wang X; Li R
    Med Mycol J; 2016; 57(4):E111-E116. PubMed ID: 27904052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.